Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Lexeo Therapeutics, Inc. | Director | Stock Option (right to buy) | 36K | Jul 5, 2024 | Direct | ||
iTeos Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 24.2K | Jun 11, 2024 | Direct | ||
RayzeBio, Inc. | Director | Stock Option (Right to Buy) | 0 | Feb 26, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LXEO | Lexeo Therapeutics, Inc. | Jul 5, 2024 | 1 | $0 | 4 | Jul 8, 2024 | Director |
LXEO | Lexeo Therapeutics, Inc. | Jul 5, 2024 | 0 | $0 | 3 | Jul 8, 2024 | Director |
ITOS | iTeos Therapeutics, Inc. | Jun 11, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
RYZB | RayzeBio, Inc. | Feb 26, 2024 | 1 | $0 | 4 | Feb 27, 2024 | Director |
RYZB | RayzeBio, Inc. | Nov 1, 2023 | 1 | $0 | 4 | Nov 1, 2023 | Director |
RYZB | RayzeBio, Inc. | Nov 1, 2023 | 0 | $0 | 3 | Nov 1, 2023 | Director |
ITOS | iTeos Therapeutics, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
ITOS | iTeos Therapeutics, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
ITOS | iTeos Therapeutics, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |